II. Epidemiology
- Normal children have recurrent infections
- Average child has 5-6 Upper Respiratory Infections/year
- Unlucky children (5%) have 11-12 URIs per year
- Otitis Media complicates URIs in 30-50% of cases
- Primary Immunodeficiency Prevalence
- United States: 83 per 100,000
- Australia: 12 per 100,000
- Sweden: 0.35 per 100,000
III. Types
- Primary Immunodeficiency
- Secondary Immunodeficiency (Acquired Immunodeficiency)
- Asplenism (e.g. splenectomy, Sickle Cell Anemia)
- Immunosuppressant
- Malnutrition
- Cancer involving Bone Marrow
- Radiation Therapy
- HIV Infection or AIDS
- Presents similarly to T-Cell Immunodeficiency Disorder
IV. Causes: Antibody or humoral (B-Cell Disorder): 78% of cases in U.S. (55% in Europe)
- General
- No B-Cells: Agammaglobulinemia
- X-Linked Agammaglobulinemia or XLA (84% of Agammaglobulinemia cases in Europe)
- Bruton Tyrosine Kinase defect (Btk gene) results in defective B-Cell maturation
- Absent peripheral B-Cells results in very low serum IgG, IgA and IgM
- Infants may have no Tonsils or Lymph Nodes on exam
- Severe respiratory infections with Encapsulated Bacteria (e.g. pneumococcus, H. Influenzae)
- Chronic Diarrhea (echoviruses and coxsackie virus), recurrent varicella
- X-Linked Agammaglobulinemia or XLA (84% of Agammaglobulinemia cases in Europe)
- Decreased B Cells or Antibody: Hypogammaglobulinemia
- IgA Deficiency (30% of U.S. cases and most common B-Cell Disorder overall in U.S.)
- Low levels or absent IgA
- Prone to respiratory or gastrointestinal infections
- May be associated with IgG2 or IgG4 deficiency
- IgG Subclass Deficiency of IgG2, IgG3, IgG4 (26% of U.S. cases)
- Common Variable Immunodeficiency or CVID (15% in U.S. and 46% in Europe of cases)
- Bimodal onset in preschool and in young adults
- Two Immunoglobulin subtypes are low (typically including Low total IgG, as well as IgM and IgA)
- B-Cells may be decreased in number and have defective function (T Cells may also be defective)
- Similar to X-Linked Agammaglobulinemia, but more mild
- Ear, sinus and lung infections occur as with other Antibody Disorders (e.g. pneumococcus, H. Influenzae)
- CVID also present with malabsorption from Infectious Diarrhea
- Examples: C. difficile, Giardia, Salmonella, Campylobacter, Yersinia
- Transient Hypogammaglobulinemia of Infancy (3% of U.S. cases)
- Increased mild Bacterial respiratory infections
- Normal nadir that corrects by age 2-4 years
- IgA Deficiency (30% of U.S. cases and most common B-Cell Disorder overall in U.S.)
- Increased Immunoglobulin: Hypergammaglobulinemia
- Hyper-Immunoglobulin E (IgE) Syndrome (Job Syndrome)
- Significantly increased IgE levels
- Skin disorders (e.g. Eczema) and infections
- Recurrent lung infections (staphylococcal empyema)
- Hyper-Immunoglobulin M or Hyper-IgM Syndrome (HIGM)
- CD40 Ligand deficiency (most common cause, X-Linked)
- T-Lymphocytes are unable to trigger B-Cells to switch Immunoglobulin production of IgM to IgG, IgA and IgE
- IgM levels increase, but other Antibody levels are deficient
- Results in recurrent and severe infections (including opportunistic infections)
- Results in increased malignancy risk
- Hyper-Immunoglobulin E (IgE) Syndrome (Job Syndrome)
V. Causes: T-Cell Disorders (9-10% of Primary Immunodeficiency in both Europe and U.S.)
- See HIV Infection (or AIDS)
-
General
- Most T-Cell Disorders are mixed T-Cell and B-Cell Disorders as B-Cells rely on T-Cells
-
Severe Combined Immunodeficiency (SCID)
- Severe T cell deficiency causes B Cell dysfunction
- X-Linked deficiency or Autosomal Recessive trait (1 in 100,000 live births in U.S.)
- Subtypes include X-Linked SCID, Autosomal RecessiveSCID, Adenosine Deaminase Deficiency
- Onset before age 3 months
- Presents with Diarrhea, opportunistic infections, severe childhood infections and Failure to Thrive
- Specific infections include Otitis Media, Mononucleosis and Candidiasis
- Survival 90% with diagnosis and Stem Cell Transplant in first 3.5 months of life (contrast with 70% after that age)
- Added to routine Newborn Screening panels in about one third of U.S. States as of 2013-14
- False Positives 1.5% in term infants and 5% Preterm Infants in NICU (will requires re-testing)
-
Ataxia Telangiectasia
- Combined humoral and cell-mediated Immunity deficiency
- Impaired DNA repair mechanisms result in IgA deficiency (and possibly IgG2 and IgE deficiency)
- Onset of Telangiectasia by age 3-6 years old
- Progressive Ataxia affecting disordered ambulation by age 10-12 years old
- Recurrent sinus and lung infections, autoimmune disorders and malignancy (e.g. Non-Hodgkin Lymphoma)
-
Wiscott-Aldrich Syndrome
- X-Linked disorder, typicalluy diagnosed around 21 months of age
- Classic triad of Thrombocytopenia, recurrent Otitis Media and Eczema (present in only 27% of cases)
- Thrombocytopenia with life threatening bleeding (GI Bleeding, Intracranial Bleeding) in up to 30% of children
-
DiGeorge Syndrome (Velocardiofacial, Congenital Thymic Aplasia)
- Deletion at 22q11.2 results in incomplete development from third and fourth pharyngeal pouches
- Thymus hypoplasia
- Hypoparathyroidism with Hypocalcemia
- Cardiac abnormalities and altered facial features
- T Lymphocyte deficiency (low T-Cell numbers and decreased or absent T-Cell response)
- Severe Viral Infections from contagious spread or from Live Vaccine
- Persistent fungal infections (e.g. Thrush persists >12 months)
- Deletion at 22q11.2 results in incomplete development from third and fourth pharyngeal pouches
VI. Causes: Phagocytic Disorders (8.5% of U.S. and 12.5% of European Primary Immunodeficiency cases)
- Background
- Phagocytes (Neutrophils and Macrophages) are critical to clearing infections
-
General
- Disorders of Neutrophils or Monocytes/Macrophages
- Fungal Lung Infections
- Recurrent abscesses or delayed Wound Healing
- May present with invasive infections
- Catalase positive infections (consider especially if invasive infections)
- Staphylococcus aureus
- Pseudomonas
- Aspergillus
- Burkholderia cepacia
- Nocardia
- Serratia
- Candida
-
Neutropenia - Decreased Absolute Neutrophil Count (ANC<500/ul)
- Chemotherapy-related Neutropenia
- Severe Congenital Neutropenia
- Presents in first few weeks of life
- Omphalitis
- Autoimmune Neutropenia
- Cyclic Neutropenia
- Neutrophil numbers fluctuate in 21 day cycle
- Decreased Neutrophil function
- Chediak-Higashi Syndrome
- Chronic Granulomatous Disease (CGD)
- Inherited PhagocyteNADPH oxidase abnormality
- Typically diagnosed by age 5 years old
- May first present as omphalitis in infants
- Recurrent in Intracellular Bacterial and fungal infections, abscesses and Granulomas
- Examples: Pneumonia, abscesses, suppurative adenitis, gastrointestinal infections
- Leukocyte adhesion deficiency (type 1)
- Adhesion molecules allow Phagocytes to adhere to vascular endothelium and migrate to infection site
- Leukocyte adhesion deficiency presents in first few weeks of life
- Delayed Umbilical Cord separation beyond 4 weeks after birth
- Omphalitis
- Other findings
- Poor Wound Healing
- Erosive perianal ulcers
- Severe Bacterial Infections (e.g. Pneumonia, chronic Skin Infections)
VII. Causes: Complement Disorders: 2% of cases
- Autoimmune Condition or Rheumatologic Condition (associated with C1-C4 deficiencies)
- Recurrent encapsulated organism, esp. pyogenic infections (manifestations vary depending on missing complement type)
- Complement deficiencies include C1q, C2-C9 (except C4), Factor I, Properdin
- Neisseria infections are most common including Meningitis, Sepsis and Arthritis (associated with C5-C9 deficiencies)
- Recurrent infections with Streptococcus Pneumoniae and HaemophilusInfluenzae (associated with C3 deficiency)
- Hereditary Angioedema
VIII. Signs: Red Flags for Primary Immunodeficiency
- Most helpful warning signs
- Positive Family History of Immunodeficiency
- History of Sepsis requiring intravenous Antibiotics
- Failure to Thrive
- Subbarayan (2011) Pediatrics 127(5): 810-6 [PubMed]
- Warning sign patterns
- Increasing frequency and severity of infections as children become older (opposite of typical pattern)
- Recurrent serious infections (at 2 or more sites) with common pathogens
- Serious, invasive infections with uncommon pathogens
- Recurrent and persistent infections
- Otitis Media (>8 episodes/year)
- Or complicated by Mastoiditis
- Severe Bacterial Sinusitis (>1 episode/year)
- Pneumonia (>1 episode/year)
- Enteric infections (e.g. Giardia, Cryptosporidium)
- Skin Abscesses
- Unusual sites of infection (e.g. liver, Spleen)
- Opportunistic infections (e.g. Aspergillus, Nocardia)
- Persistant Thrush after age 1 year
- Infection despite >2 months of Antibiotic use
- Infection clears only with ParenteralAntibiotics
- Otitis Media (>8 episodes/year)
- Physical findings
- Miscellaneous
- Family History of Primary Immunodeficiency
- Autoimmune Disease (e.g. ITP or Hemolytic Anemia)
IX. Differential Diagnosis
- Asthma or atopic condition
- Cystic Fibrosis
- Secondary Immunodeficiency
- See Types section above
X. Labs
- Initial Screening
- Complete Blood Count with manual differential
- Screens for T-Cell Disorders and Phagocytic disorders
- See Absolute Lymphocyte Count discriminatory levels under T-Cell Disorders below
- Low Neutrophil Count (ANC <1500/mm3) may suggest cause for phagocytic disorder
- Serum Immunoglobulin levels
- Complement Levels
- Complement C3 (Intrinsic and Extrinsic Pathway Function)
- Complement C4 (Intrinsic Pathway Function, deficiency in 11% of SLE patients, 1% of U.S. population)
- CH50 (Entire Intrinsic Pathway Function)
- Peripheral Smear
- Howell-Jolly bodies suggests Asplenism
- HIV Test
- Age 18 months or older
- HIV Antibody testing is sufficient
- Age under 18 months
- Obtain HIV DNA PCR or HIV RNA at age 14-21 days, age 1 month and age 4-6 months
- Age 18 months or older
- Complete Blood Count with manual differential
- Specific Immunodeficiency testing
- B-Cell function and Antibody Tests (Humoral Immunity)
- Step 1: Quantitative serum IgG, IgM, IgE and IgA levels
- IgG subclasses (IgG 1-4) are usually not helpful
- Low serum Immunoglobulin levels should prompt Serum Albumin testing
- Hypoalbuminemia (e.g. Proteinuria or malabsorption) may cause secondary Immunodeficiency
- Step 2: Response to Vaccine (if step 1 Immunoglobulin levels are low)
- Obtain pre-Vaccine titers
- Administer Vaccine
- Measure post-Vaccine titers at 4 weeks (3 weeks if two or more prior same antigen Vaccinations)
- Expect 2 to 2.5 fold titer increase after Vaccination
- Failed titer increase suggests Humoral Immunodeficiency
- Step 1: Quantitative serum IgG, IgM, IgE and IgA levels
- T-Cell Function Tests
- Absolute Lymphocyte Count (ALC, done in CBC)
- Unlikely if normal Lymphocyte Count
- Newborn: <3000/mm3 suggests T-Cell Disorder
- Infant or child with ALC at 2 S.D. below mean suggests T-Cell Disorder (especially SCID)
- Delayed-Type Hypersensitivity (age >1 year old)
- Lymphocyte subset analysis (percentage estimates)
- T Cells (CD3, CD4, CD8)
- B Cells (CD19, CD20)
- Natural Killer Cells (CD16, CD56)
- Absolute Lymphocyte Count (ALC, done in CBC)
- Phagocytosis function tests
- Absolute Neutrophil Count (ANC) <1500/mm3
- Granulocyte function tests
- Flow cytometry for Neutrophil oxidative burst
- Complement function tests
- Total complement or CH50 (test when well)
- If abnormal, test alternative pathway (CH100 or AH50)
- B-Cell function and Antibody Tests (Humoral Immunity)
XI. Management
- See precautions below (Vaccines, Blood Products)
- Avoid Microorganism exposure (e.g. Face Masks in public)
- Obtain Genetic Counseling if Primary Immunodeficiency identified
- Prophylaxis
- Prophylactic Antibiotics
- Intravenous Immunoglobulin (IVIG) or Subcutaneous Immunoglobulin for specific Humoral Immunodeficiency
- Bone Marrow Transplant Indications
XII. Precautions
- Vaccines to avoid in patients and their close contacts
-
Blood Products
- Specific precautions depending on condition
XIII. Resources
- National Primary Immunodeficiency Resource Center
- Immune Deficiency Foundation
XIV. References
- Mahmoudi (2014) Immunology Made Ridiculously Simple, MedMaster, Miami, FL
- Cooper (2003) Am Fam Physician 68:2001-11 [PubMed]
- Reust (2013) Am Fam Physician 87(11): 773-8 [PubMed]
- Rosen (1995) N Engl J Med 333(7):431-440 [PubMed]